Biologics

A new study published in Spine examines 30- and 90-day readmission rates for spinal fusions.

Clinical stage regenerative medicine company, SpinalCyte, now features research studies on its website outlining the potential benefits of fibroblast technology.

Fort Collins, Colo.-based bioavailable cannabis solutions company, Geocann, hired Anthony Petraglia, MD, as CMO, and chairman of the Scientific and Medical Advisory Board.

Five spine surgeons discuss where they expect technology to evolve over the next half-decade.

A new study published in Spine examines bone graft substitutes for one- and two-level anterior cervical discectomy and fusion.

Vail, Colo.-based Steadman Clinic's Matthew Provencher, MD, received AlloSource's Dr. Steven Gitelis Inspiration Award to recognize his work using donated human tissue to help patients heal.

Marietta, Ga.-based biopharmaceutical company MiMedx has appointed Timothy Wright as its new CEO.

Orthopedic surgeon at San Diego-based Grossmont Hospital Scott A. Hacker, MD, treated the first four patients in the west coast with medical device company CartiHeal's Agili-C cartilage regeneration implant.

San Antonio-based nonprofit BioBridge Global has added orthopedic surgeon Michael J. Yaszemski, MD, PhD, to its regenerative medicine advisory board.

New York-based medical device manufacturer Misonix agreed to acquire privately held wound-healing company Solys Medical of Newport News, Va., in an all-stock transaction valued at $97 million.